InnaVirVax Announces Presentation of the Results of Its Phase I/IIa Clinical Study at CROI 2013 in Atlanta
3/5/2013 2:59:22 PM
More...
|
InnaVirVax Announces Publication of an Article in JAIDS (Journal of Acquired Immune Deficiency Syndromes)
3/1/2013 11:41:12 AM
More...
|
InnaVirVax: the Phase I/IIa Clinical Study of Its VAC-3S Immunotherapeutic Vaccine in the Treatment of HIV Infection Has Achieved Its Primary Endpoint
11/30/2012 1:41:55 PM
More...
|
InnaVirVax Strenghtens Patent Protection of VAC-3S Immunotherapy
6/18/2012 11:46:37 AM
More...
|
InnaVirVax Announces the Launch of the First Clinical Trial on VAC-3S, a Novel Immunotherapy for the Treatment of HIV-1 Infections
3/5/2012 9:19:53 AM
More...
|